DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,071 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $238,259 | +0.1% | 954 | 0.0% | 0.17% | +2.5% |
Q1 2024 | $238,124 | -7.1% | 954 | -13.8% | 0.16% | -15.2% |
Q4 2023 | $256,214 | -0.7% | 1,107 | +6.5% | 0.19% | -16.6% |
Q3 2023 | $257,891 | +3.4% | 1,039 | 0.0% | 0.23% | +6.5% |
Q2 2023 | $249,461 | -25.7% | 1,039 | -21.9% | 0.22% | +1.9% |
Q1 2023 | $335,560 | -10.0% | 1,331 | -5.3% | 0.21% | -13.2% |
Q4 2022 | $373,000 | +0.5% | 1,406 | -2.1% | 0.24% | -9.7% |
Q3 2022 | $371,000 | +0.8% | 1,436 | -1.1% | 0.27% | +8.5% |
Q2 2022 | $368,000 | -18.8% | 1,452 | -6.0% | 0.25% | -3.9% |
Q1 2022 | $453,000 | -10.8% | 1,544 | 0.0% | 0.26% | -6.5% |
Q4 2021 | $508,000 | +7.4% | 1,544 | -0.5% | 0.28% | -2.1% |
Q3 2021 | $473,000 | +12.9% | 1,552 | -0.6% | 0.28% | +11.0% |
Q2 2021 | $419,000 | +20.7% | 1,562 | +1.2% | 0.25% | +10.9% |
Q1 2021 | $347,000 | +3.3% | 1,543 | +2.0% | 0.23% | -5.0% |
Q4 2020 | $336,000 | -0.3% | 1,513 | -3.2% | 0.24% | -10.4% |
Q3 2020 | $337,000 | +22.1% | 1,563 | 0.0% | 0.27% | +10.7% |
Q2 2020 | $276,000 | +34.0% | 1,563 | +5.0% | 0.24% | +16.8% |
Q1 2020 | $206,000 | -13.4% | 1,489 | -9.5% | 0.21% | -7.1% |
Q3 2019 | $238,000 | +1.3% | 1,645 | 0.0% | 0.22% | -11.1% |
Q2 2019 | $235,000 | +9.8% | 1,645 | +1.7% | 0.25% | +7.7% |
Q1 2019 | $214,000 | – | 1,618 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |